Current Research & Future Challenges

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

 

    Related Conference of Current Research & Future Challenges

    November 26-27, 2021

    33rd Annual Congress on Immunology and Vaccinations

    Vancouver, Canada
    December 01-02, 2021

    41st Global Summit and Expo on Vaccines & Immunology

    Frankfurt, Germany
    March 09-10, 2022

    6th International Conference on Vaccines and Immunology

    Geneva, Switzerland
    April 18-19, 2022

    Global Summit on Vaccines and Immunology

    Madrid, Spain
    October 07-08, 2022

    34th International Conference on Vaccines and Immunization

    Zurich, Switzerland

    Current Research & Future Challenges Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in